To investigate if multiple myeloma cells engage TIM-3-, LAG-3- and 2B4-mediated pathways, we analyzed the expression of IR ligands in two multiple myeloma cell lines (U266 and MM1.s) in both resting conditions and in pro-inflammatory conditions. The gene discussed is HAVCR2; the disease is plasma cell myeloma.